These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 569029)
1. [A new strategy of fight against meningococcal meningitis epidemics in Sahelian Africa]. Saliou P; Rey JL; Stoeckel PH Bull Soc Pathol Exot Filiales; 1978; 71(1):34-45. PubMed ID: 569029 [TBL] [Abstract][Full Text] [Related]
2. [Controlled tests of anti-meningococcal polysaccharide A vaccine in the African Sahel area (Upper Volta and Mali) ]. Saliou P; Stoeckel P; Lafaye A; Rey JL; Renaudet J Dev Biol Stand; 1978; 41():97-108. PubMed ID: 572789 [TBL] [Abstract][Full Text] [Related]
3. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies]. Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV Sante; 1997; 7(6):384-90. PubMed ID: 9503496 [TBL] [Abstract][Full Text] [Related]
4. Serogroup A meningococcal conjugate vaccine coverage after the first national mass immunization campaign-Burkina Faso, 2011. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(50):1022-4. PubMed ID: 23254256 [TBL] [Abstract][Full Text] [Related]
5. Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine. LaForce FM; Okwo-Bele JM Health Aff (Millwood); 2011 Jun; 30(6):1049-57. PubMed ID: 21653956 [TBL] [Abstract][Full Text] [Related]
6. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997]. da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I Sante; 2003; 13(4):215-23. PubMed ID: 15047438 [TBL] [Abstract][Full Text] [Related]
7. [Control of an epidemic of meningococcal meningitis in Central Africa]. Merlin M; Martet G; Debonne JM; Nicolas P; Bailly C; Yazipo D; Bougère J; Todesco A; Laroche R Sante; 1996; 6(2):87-95. PubMed ID: 8705135 [TBL] [Abstract][Full Text] [Related]
8. Risk of epidemic meningitis in Africa: a cause for concern. Wkly Epidemiol Rec; 2007 Mar; 82(10):79-87. PubMed ID: 17348094 [No Abstract] [Full Text] [Related]
9. Evaluation of meningitis surveillance before introduction of serogroup a meningococcal conjugate vaccine - Burkina Faso and Mali. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(50):1025-8. PubMed ID: 23254257 [TBL] [Abstract][Full Text] [Related]
10. [Epidemiological and control aspects of meningococcal meningitis epidemics in Africa]. Spiegel A; Moren A; Varaine F; Baudon D; Rey M Sante; 1994; 4(3):231-6. PubMed ID: 7921694 [TBL] [Abstract][Full Text] [Related]
11. [Optimizing the response to epidemics of meningococcal meningitis: report of a workshop of experts at CERMES (Niamey, Niger, 12th to 14th January 1998)]. Chippaux JP; Soula G; Campagne G; Rey M Sante; 1998; 8(3):245-8. PubMed ID: 9690327 [TBL] [Abstract][Full Text] [Related]
12. Surveillance and control of meningococcal meningitis epidemics in refugee populations. Moore PS; Toole MJ; Nieburg P; Waldman RJ; Broome CV Bull World Health Organ; 1990; 68(5):587-96. PubMed ID: 2289295 [TBL] [Abstract][Full Text] [Related]
17. A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A. Erwa HH; Haseeb MA; Idris AA; Lapeyssonnie L; Sanborn WR; Sippel JE Bull World Health Organ; 1973; 49(3):301-5. PubMed ID: 4211056 [TBL] [Abstract][Full Text] [Related]
18. Intercountry meningitis meeting: preparing for the next epidemic seasons, Mali, October 2006. Wkly Epidemiol Rec; 2007 Feb; 82(5):34-40. PubMed ID: 17274150 [No Abstract] [Full Text] [Related]
19. The outbreak of meningitis due to Neisseria meningitidis W135 in 2003 in Burkina Faso and the national response: main lessons learnt. Zombré S; Hacen MM; Ouango G; Sanou S; Adamou Y; Koumaré B; Kondé MK Vaccine; 2007 Sep; 25 Suppl 1():A69-71. PubMed ID: 17630052 [TBL] [Abstract][Full Text] [Related]
20. Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience. Djingarey MH; Barry R; Bonkoungou M; Tiendrebeogo S; Sebgo R; Kandolo D; Lingani C; Preziosi MP; Zuber PL; Perea W; Hugonnet S; Dellepiane de Rey Tolve N; Tevi-Benissan C; Clark TA; Mayer LW; Novak R; Messonier NE; Berlier M; Toboe D; Nshimirimana D; Mihigo R; Aguado T; Diomandé F; Kristiansen PA; Caugant DA; Laforce FM Vaccine; 2012 May; 30 Suppl 2():B40-5. PubMed ID: 22607898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]